Clinical Trial Update: Tolerability and Safety of Nintedanib in Myositis Associated Interstitial Lung Disease [NA]

View source ↗

Summary

This clinical trial update describes tolerability and safety data for nintedanib in patients with myositis-associated interstitial lung disease; the trial has b…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Interstitial Lung Disease
• Myositis

Drugs mentioned

• Nintedanib (nintedanib)

Snippet

Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre | Conditions: Interstitial Lung Disease, Myopathy, Inflammatory | NA | Status: TERMINATED